Pfizer Inc. (PFE) trades on NYSE and is classified in the Healthcare sector. Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. This page tracks PFE using verified market data, the company's most recently reported financial statements, its earnings record and Ticker-Terminal's analytical models. Every figure is shown with its source and the time it was last verified, and values we cannot verify are labelled rather than filled in.
Previous close
$27.65
Volume
25,557,178.203
52-week range
$23.58 – $29.21
Market cap
$157.99B
Source: Polygon (daily close) · Verified Sep 11, 2026, 12:00 AM EDT
1D
+0.25%
1W
-2.57%
1M
+5.36%
1Y
+11.50%
Percentage change calculated from verified closing prices. Periods without full provider coverage are marked unavailable rather than estimated.
Revenue (TTM)
Reported Q2'26 · Polygon (company financials)
Revenue growth (YoY)
Reported Q2'26 · Polygon (company financials)
EPS (TTM, diluted)
Reported Q2'26 · Polygon (company financials)
EPS growth (YoY)
Reported Q2'26 · Polygon (company financials)
Gross margin
Reported Q2'26 · Polygon (company financials)
Operating margin
Reported Q2'26 · Polygon (company financials)
Net margin
Reported Q2'26 · Polygon (company financials)
Operating cash flow (TTM)
Reported Q2'26 · Polygon (company financials)
Revenue 2-year CAGR
Reported Q2'26 · Polygon (company financials)
Source: Polygon financials + Finnhub earnings · Latest reported Q2'26 · Verified Aug 3, 2026, 8:00 PM EDT
P/E (trailing)
Reported Q2'26 · Ticker-Terminal (last verified price ÷ TTM diluted EPS)
P/E (forward, est.)
Ticker-Terminal (last verified price ÷ annualised consensus EPS estimate)
Market cap
Polygon / Finnhub reference
Dividend yield
Ticker-Terminal does not publish a dividend yield for this ticker until a verified distribution is on file.
Next earnings date
Nov 1, 2026
Source: Finnhub earnings calendar
Latest reported quarter
Q2'26
Revenue $15.03B · Diluted EPS -0.04
| Period | EPS actual | Estimate | Surprise |
|---|---|---|---|
| 2026-06-30 | 0.77 | 0.69 | +11.4% |
| 2026-03-31 | 0.75 | 0.72 | +3.5% |
| 2025-12-31 | 0.66 | 0.58 | +14.3% |
| 2025-09-30 | 0.87 | 0.64 | +36.0% |
Analysis paused: current market inputs are not fresh enough to update it.
Analysis paused: current market inputs are not fresh enough to update it.
Rating
Hold
Average target
Unavailable
Range
Unavailable
Analysts
36
Source: finnhub
Zacks Investment Research · Sep 10, 2026
GlobeNewswire Inc. · Sep 8, 2026
The Motley Fool · Sep 8, 2026
The Motley Fool · Sep 8, 2026
Zacks Investment Research · Sep 8, 2026
The Motley Fool · Sep 8, 2026
Some data is delayed, stale or unavailable. Everything shown is still verified.
Company profile and business overview · Reported financial statements · Earnings history
This page is the free public summary. Inside Ticker-Terminal you get quarterly forecasts, EPS estimate tracking, earnings deep dives, fair-value modelling and AI research built on the same verified provider data and filings.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer Inc. trades under the ticker PFE on NYSE.
PFE was last verified at $27.72 (0.25% on the day). Pre-market, last verified Sep 11, 2026, 12:00 AM EDT. Market data may be delayed and is shown with its own timestamp.
Based on the latest reported financials, PFE revenue changed 2.6% year over year (filed Aug 3, 2026).
The next confirmed PFE earnings date is Nov 1, 2026, per Finnhub earnings calendar. Dates can be revised by the company.
For Q2'26, PFE reported revenue of $15.03B and diluted EPS of -0.04.
Create a free Ticker-Terminal account to run a full AI research report on PFE — earnings breakdown, quarterly forecasts, bull, base and bear cases, and fair value ranges built on verified provider data and filings.
Free guide series
Two emails. The 7-step checklist now, then the next guide in the series — starting with Which AI is best for stock research.
Market data on this page is supplied by third-party providers, may be delayed, and is shown with the time it was last verified. Financial figures come from PFE's most recently reported statements and are not restated by Ticker-Terminal.
Scores, fair-value ranges and bull, base and bear scenarios are analytical models calculated from verified data. They are educational information, not investment advice, not a price prediction, and not a recommendation to buy or sell any security. Past performance does not indicate future results.
See our risk disclosure. Page data assembled Sep 14, 2026, 4:07 AM EDT.